Host
Alleles
Animals
Biomarkers, Tumor
Cell Line, Tumor
Cell Transformation, Neoplastic
/ genetics
Disease Models, Animal
Disease Progression
Female
Genotype
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
/ genetics
Male
Mice
Mice, Transgenic
Mutation
Pancreatic Neoplasms
/ genetics
Polymorphism, Single Nucleotide
Proto-Oncogene Proteins p21(ras)
/ genetics
Treatment Outcome
Xenograft Model Antitumor Assays
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500
Informations de publication
Date de publication:
15 01 2019
15 01 2019
Historique:
received:
21
03
2018
revised:
16
07
2018
accepted:
25
09
2018
pubmed:
30
9
2018
medline:
28
2
2020
entrez:
30
9
2018
Statut:
ppublish
Résumé
Heritable genetic variations can affect the inflammatory tumor microenvironment, which can ultimately affect cancer susceptibility and clinical outcomes. Recent evidence indicates that IDO2, a positive modifier in inflammatory disease models, is frequently upregulated in pancreatic ductal adenocarcinoma (PDAC). A unique feature of PDAC development was notably decreased in the The results of this study provide genetic support for IDO2 as a contributing factor in PDAC development and argue that
Identifiants
pubmed: 30266763
pii: 1078-0432.CCR-18-0814
doi: 10.1158/1078-0432.CCR-18-0814
pmc: PMC6335160
mid: NIHMS1508664
doi:
Substances chimiques
Biomarkers, Tumor
0
IDO2 protein, human
0
Indoleamine-Pyrrole 2,3,-Dioxygenase
0
KRAS protein, human
0
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
724-734Subventions
Organisme : NCI NIH HHS
ID : P30 CA056036
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA191191
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA212600
Pays : United States
Informations de copyright
©2018 American Association for Cancer Research.
Références
JAMA. 2013 Oct 9;310(14):1473-81
pubmed: 24104372
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):911-7
pubmed: 25220717
Cancer. 2016 Sep 1;122(17):2671-9
pubmed: 27243381
Fam Cancer. 2015 Mar;14(1):95-103
pubmed: 25240578
Nat Med. 2005 Mar;11(3):312-9
pubmed: 15711557
JAMA. 2010 Sep 8;304(10):1073-81
pubmed: 20823433
N Engl J Med. 2004 Mar 18;350(12):1200-10
pubmed: 15028824
Cancer Immunol Immunother. 2014 Jul;63(7):721-35
pubmed: 24711084
Cancer Res. 2007 Aug 1;67(15):7082-7
pubmed: 17671174
J Clin Oncol. 2014 Feb 20;32(6):504-12
pubmed: 24419109
Genes Dev. 1998 Dec 15;12(24):3797-802
pubmed: 9869632
Cancer Res. 2017 Dec 15;77(24):6795-6811
pubmed: 29247038
Trends Immunol. 2016 Mar;37(3):193-207
pubmed: 26839260
Oncoimmunology. 2016 Mar 10;5(6):e1149674
pubmed: 27471617
J Am Coll Surg. 2008 May;206(5):849-54; discussion 854-6
pubmed: 18471709
Cancer Discov. 2016 Mar;6(3):256-69
pubmed: 26715642
Lancet. 2017 Mar 11;389(10073):1011-1024
pubmed: 28129987
Cancer Discov. 2016 Mar;6(3):270-85
pubmed: 26715645
Cancer Immunol Immunother. 2009 Jan;58(1):153-7
pubmed: 18418598
Cancer Immunol Res. 2015 Sep;3(9):978-85
pubmed: 26269528
J Am Coll Surg. 2018 Apr;226(4):596-603
pubmed: 29426021
J Surg Oncol. 2014 Dec;110(8):960-6
pubmed: 25146251
Cancer Immunol Res. 2015 Feb;3(2):161-72
pubmed: 25271151
J Immunol. 2014 Mar 1;192(5):2082-2090
pubmed: 24489090
PLoS One. 2017 Sep 8;12(9):e0184455
pubmed: 28886117
J Radiat Oncol. 2013 Sep 1;2(3):
pubmed: 24187608
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Cancer Res. 2018 Feb 1;78(3):809-816
pubmed: 29118088
Clin Cancer Res. 2016 Sep 1;22(17):4328-40
pubmed: 26979392
Genome Biol. 2016 Oct 20;17(1):218
pubmed: 27765066
J Immunol. 2014 Feb 1;192(3):1231-40
pubmed: 24391212
Am J Clin Oncol. 2018 Mar;41(3):242-247
pubmed: 26757436
Semin Cancer Biol. 2018 Oct;52(Pt 2):241-252
pubmed: 29258858
J Immunol. 2016 Jun 1;196(11):4487-97
pubmed: 27183624
Cancer Res. 2007 Jan 15;67(2):792-801
pubmed: 17234791
Pancreat Disord Ther. 2015 Jun;5(2):
pubmed: 26779392
J Exp Med. 2013 Jul 1;210(7):1389-402
pubmed: 23752227
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Biochem Biophys Res Commun. 2008 Oct 24;375(3):331-5
pubmed: 18694728
Int Immunol. 2014 Jul;26(7):357-67
pubmed: 24402311
Cancer Cell. 2003 Dec;4(6):437-50
pubmed: 14706336
J Gastrointest Surg. 2015 Dec;19(12):2183-91
pubmed: 26376994
Clin Cancer Res. 2000 Aug;6(8):2969-72
pubmed: 10955772
Clin Cancer Res. 2016 Aug 15;22(16):4057-66
pubmed: 26994146
J Am Coll Surg. 2009 May;208(5):781-7; discussion 787-9
pubmed: 19476837
J Stat Softw. 2010 Aug;36(2):
pubmed: 25285054
Am J Clin Oncol. 2017 Apr;40(2):109-117
pubmed: 28230650
Methods Enzymol. 2008;439:73-85
pubmed: 18374157
Crit Rev Oncog. 1993;4(4):435-49
pubmed: 8353142